Fundraising FoxHealthtech Startups
18,759 companies tagged Healthtech, with their investors and founders.
0 investors
Myca Health provides an electronic health record platform, practice management system, and patient portal for clinicians and healthcare practices. The cloud-based solution enables patient engagement, automated workflows, and integrated billing across medical practices.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Brentwood, Tennessee home-based nursing and post-acute benefits manager for health plans, acquired by Anthem in 2021.
0 investors
Myocardial Solutions develops MyoStrain, a cardiac MRI technology that measures regional heart function for clinical and research use. The company serves healthcare institutions and medical professionals in the cardiology and imaging sectors.
0 investors
Myosana Therapeutics develops non-viral, muscle-targeted gene therapies aimed at slowing skeletal muscle degeneration and heart failure in Duchenne muscular dystrophy (DMD) and other neuromuscular and cardiac diseases. The company works in the biotech and gene therapy field.
0 investors
0 investors
Myrtelle develops gene therapies for neurological diseases, particularly white matter disorders of the central nervous system. The company is conducting clinical trials for Canavan disease using novel AAV vector technology to target oligodendrocytes.
0 investors
0 investors
0 investors
0 investors
0 investors
Naba Health operates in primary care healthcare, building the technology behind Mizan Clinic. The company provides primary care services and the systems that power its clinic offering.
0 investors
Namida is an early cancer detection company. The referenced page is a biography of an advisory board member rather than a description of the company's products.
0 investors
NannoCare makes NannoPad, organic cotton sanitary pads that use its Nannogenic far-infrared technology to help relieve menstrual cramps and discomfort. The direct-to-consumer products target women seeking natural period care and menstrual pain relief.
0 investors
Nanoscope Therapeutics develops therapies for patients with complex retinal diseases that have high unmet need, including inherited retinal degenerations. The company focuses on treatments aimed at restoring vision in people affected by retinal blindness.
0 investors
NanoViricides develops antiviral drugs using nanomedicine technology designed to directly attack and destroy virus particles by mimicking host cell surface features that viruses use for infection. The company's platform approach targets multiple viral families including coronavirus, herpes, HIV, and influenza through a mechanism intended to prevent viral resistance, with its lead candidate in Phase II clinical development.
0 investors
0 investors
0 investors
0 investors